CVS signs up for at-home test kits to lure more people to its pharmacy: We unpack how CVS’s deal with ixlayer dovetails with its retail health strategy.
How price transparency regulations are impacting consumers: Patients aren’t shopping around for costs of healthcare services even as payers and providers are required to post prices—but that could change amid economic pressures.
Highmark’s DTx coverage decision opens up access to digital therapies: We dig into the insurer’s policy change on digital therapeutics and its impact on consumer accessibility.
UPMC pilots Pip Care to prep patients for surgical procedures: The VC-backed startup's solution covers everything from appointments to lifestyle choices that could shorten hospital stays.
In an era of uncertainty, healthcare providers still buy tech: Most hospitals and health systems aren’t pressing pause on software investments. We analyze what’s driving the spending and where the money is going.
Millennials like mobile health monitoring: We detail new Kantar data that reveals whether different generations think remote monitoring devices can help their doctors.
Digital health startups to watch: We spotlight why digital AI-powered imaging company Prenuvo and behavioral health tech startup NeuroFlow are worth watching.
Healthcare organizations feel the costs of ransomware attacks: We analyze the debilitating impact ransomware incidents have on healthcare entities and why providers must examine the whole supply chain for optimal protection.
What’s going to ail us in 2023? We unpack the top medical conditions health insurers predict will drive up spending in 2023 from Willis Tower Watson’s 2023 Global Medical Trends Survey.
Are smart TVs the new telehealth frontier? Consumer electronics giants like Samsung are getting in on the shift to home-based healthcare with telehealth integrations.
Seniors are bearish on retail health: Younger consumers are more likely than older ones to try out retail health clinics. We explore how retailers can step up to reach more seniors.
GoodRx wants patients to actually take their meds: It's equipping doctors with more reliable Rx information with its new tool, Provider Mode, to get the job done.
DexCare buys Womp: Here’s how they plan to bring ecommerce and online merchandising technology to healthcare clients.
Walgreens doubles down on home health: The pharmacy chain is racing CVS and other rivals to dominate the surging home healthcare sector.
Babylon pivots to digital-first contracts: We unpack Babylon’s fiscal struggles and why its decision to sell off Meritage Medical Network doesn’t align with the company’s new direction.
Digital health startups to watch: We spotlight why digital LGBTQIA+ healthcare provider Folx Health and Medicaid-focused virtual mental health company Brave Health are worth watching.
Mark Cuban’s online pharmacy shifts business strategy: We explore Cost Plus Drugs’ first collaborations with a PBM and health plan and analyze why the pharmacy decided to pivot away from operating all on its own.
Walmart officially enters the clinical trial space: We unpack Walmart’s latest healthcare venture and why retail clinics are well positioned to help circumvent clinical trial roadblocks.
Home-based SDOH interventions prove worthwhile: New data highlights which SDOH programs deliver value to providers and health plans. We detail how organizations can devise a successful SDOH strategy.